USpolicy

News

CDER head Tidmarsh 'on leave' and is sued by drugmaker

George Tidmarsh is no longer at the helm of CDER and is facing a lawsuit claiming he abused his position there to harm a former business associate.

News

Medical group advises against leucovorin for autism

The American Academy of Paediatrics has warned against leucovorin as a treatment for autism, citing a lack of evidence on safety and efficacy.

News

FDA plan will cut testing requirements for biosimilars

The FDA has proposed a radical change to the regulatory requirements for bringing biosimilar medicines to market as a way to cut US drug prices.

News

Falling flu vaccine sales in US stall CSL's Seqirus spinout

CSL says flu vaccination rates in the US are expected to fall 12% to 14% this year, and have scuppered its plan to spin out its vaccines unit Seqirus.

News

Texas sues J&J, Kenvue over Tylenol autism claim

Texas has filed a lawsuit against J&J and Kenvue over the debunked claim that Tylenol causes autism, recently trumpeted by President Trump.

News

ICER says US new drug launch prices have risen sharply

ICER says the prices of new drug launches in the US rose 51% in three years, adding up to $1.5bn in first-year costs to US health systems.

CDER head Tidmarsh 'on leave' and is sued by drugmaker

Medical group advises against leucovorin for autism

FDA plan will cut testing requirements for biosimilars

Falling flu vaccine sales in US stall CSL's Seqirus spinout

Texas sues J&J, Kenvue over Tylenol autism claim

ICER says US new drug launch prices have risen sharply

Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer

Discover a new era of healthcare panel engagement: Grounded ...

USpolicy

Editor's Picks